Company: Cellectar Biosciences Inc.
Job title: Chief Operating Officer
Understanding Novel Conjugate Platforms for Enhanced Therapeutic Response & Manufacturing Ease 12:00 pm
Evaluating the benefits of the novel Phospholipid Ether approach Unique manufacturing challenges presented by this approach Supply chain pros and cons related to non-radio componentsRead more
day: Conference Day Two